Pituitary control of ovarian function--concepts derived from gonadotrophin therapy.
about
Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndromeInterventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)The physiology of follicle selectionDetermination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulationAndrostenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation inductionGonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.Types of ovarian activity in women and their significance: the continuum (a reinterpretation of early findings).Cessation of gonadotropin-releasing hormone antagonist on triggering day: an alternative method for flexible multiple-dose protocolRecombinant luteinizing hormone supplementation in women undergoing in vitro fertilization/ intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis.Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.Ovulation induction with minimal dose of follitropin alfa: a case series studySerum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI CyclesA case report: successful pregnancy after controlled ovarian hyperstimulation by using short-acting gonadotropin releasing hormone agonist only.Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndromeInsulin Receptor Substrate 1, the Hub Linking Follicle-stimulating Hormone to Phosphatidylinositol 3-Kinase ActivationAssessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley ratsProgesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cyclesDizygotic twinning.Dynamic changes in glycosylation and glycan composition of serum FSH and LH during natural ovarian stimulation.Approaches to improve the diagnosis and management of infertilityCurrent trends in the treatment of polycystic ovary syndrome with desire for children.Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation.Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.Corifollitropin alfa for female infertility.Follicle-Stimulating Hormone: A Review of Form and Function in the Treatment of Infertility.Can IVF influence human evolution?The role of follicle-stimulating hormone in the selection of follicles in human ovaries: a survey of the literature and a proposed model.Metformin does not improve the reproductive or metabolic profile in women with polycystic ovary syndrome (PCOS).Dimeric inhibins in girls from birth to adulthood: relationship with age, pubertal stage, FSH and oestradiol.FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives.Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation raRecombinant follicle-stimulating hormone (follitropin alfa) for ovulation induction in Japanese patients with anti-estrogen-ineffective oligo- or anovulatory infertility: results of a phase II dose-response study.The Use of Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide Excretion Rates to Navigate the Continuum of Ovarian Activity.Pilot study of the optimal protocol of low dose step‐up follicle stimulating hormone therapy for infertile women.
P2860
Q24188044-DFBA9433-35D1-4561-AC0B-A9D01C5DF2A8Q24240361-C86AF97F-0F2E-4AFB-96F6-E923A0926B7AQ24799504-2CE2085B-7FED-41C4-9D84-20EF85A839ADQ28361934-936CF86C-105C-46B6-AF4B-37723C916387Q33667893-0A591E5E-6AF5-474F-80BB-C74EE8F9BCFBQ33881072-BBD7DCAF-F47C-466F-8AB5-D388E4ED2527Q33921751-807A4E1F-E4B1-4DA1-8E79-A7C6DE9F798FQ34575178-5FC0F619-9ECF-4F35-8637-428A778F80A1Q34607007-9FBB3629-8E10-4872-9A64-1CC56DFA657FQ34631083-9C9C8C95-EE43-4D60-A75A-3A9E8A274592Q35186943-A08C63E9-1F33-4FBD-920D-E8B0978948E4Q35544136-41B3790D-D8F4-4D3A-8B70-D0C177E7C8FDQ35810513-72964641-CCE2-43D8-9B20-ABE20F2E8405Q35845572-D7BE6064-DDFD-4E33-9052-3BE6FFA33C3FQ36270486-2600EEDB-5FD9-4D5F-9A15-7AE48AAD5EBFQ36311604-6E8098D5-6367-49A0-9FFA-F2ECD0F90E9AQ36744533-D597285E-5CCA-4949-BF7B-2DFC995E326AQ36808666-871404AC-8E7F-45E5-B88F-DD4B18E2D02BQ36825733-B9CF7486-0ADA-425C-A733-FE6DCEBE1161Q37007519-378DFE01-05C3-49C3-ABDE-3996963429F1Q37019056-053DF45E-EC95-4BB1-9BF8-58EFEA9B2513Q37214916-524EC25D-9C22-49EC-98AB-513F46488D44Q37230319-F9F6D326-5DE5-4B23-A12B-EDDA65E0393EQ37658028-4F2298C2-C29A-4F7D-A87F-B2D42EB1B626Q37931055-6EC2F396-5668-409A-867A-65373F63A572Q37962998-DDD1021C-1597-4CAD-9246-DEAA0026DDFAQ38601686-C67CE807-3A75-400A-8230-F812C868B2D0Q38812185-26A58A57-D111-4168-BCFE-8C68ED81A182Q41061355-A8F89C2C-33A2-46A1-B8D2-2D0C84014331Q43289470-E977E8CD-1D27-43B5-9DB7-163A9749C2AEQ43902760-146A4266-5B23-4F29-9870-6B16AB105106Q43967288-484FF5C6-517B-4203-8DED-A1668F8A29FCQ48679851-75600007-990C-48DE-BC89-3FAB0DE5C03BQ55070527-03CDCB68-FFD7-4F0E-AD7A-EC60E33192C2Q55331508-3F30C702-8FEC-4127-AEC1-75C22F16E2B6Q55664512-06275F8C-8F7C-4186-AA13-504188F69F26
P2860
Pituitary control of ovarian function--concepts derived from gonadotrophin therapy.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Pituitary control of ovarian function--concepts derived from gonadotrophin therapy.
@en
type
label
Pituitary control of ovarian function--concepts derived from gonadotrophin therapy.
@en
prefLabel
Pituitary control of ovarian function--concepts derived from gonadotrophin therapy.
@en
P1476
Pituitary control of ovarian function--concepts derived from gonadotrophin therapy.
@en
P2093
P356
10.1111/J.1479-828X.1978.TB00011.X
P577
1978-02-01T00:00:00Z